View from Both Sides of the Table
Scott DeWire, US Head of BD&L shares experiences that have taught him first-hand the foundations of successful partnerships
Search
Innovation in medicinal chemistry
Darryl McConnell, Senior Vice President and Research Site Head, Austria and Jürgen Mack, Vice-President, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
New approaches in the battle against heartworm disease
Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. We explore the potential for novel treatments and vaccines based on new knowledge and technology.
Acute Ischaemic Stroke
Acute Ischaemic Stroke
Improving Access to Healthcare
According to the UN Sustainable Development Goals, almost half of the global population is not covered by essential health services.
Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future
Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats
COVID-19 Supply Chain and Production
COVID
SIRPα Cancer Immunology Research
Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
Our Curiosity Never Stops
Dr. Cornelia Dorner-Ciossek shares her thoughts on the future of brain disease research.
Generalized pustular psoriasis at EADV
Dr. Emmanuelle Clerisme-Beaty reflects on the latest developments for generalized pustular psoriasis at this year’s virtual EADV congress
The little things
In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
Harold and Dorothy – Full Story
T2D and CVD animation the full story – learn about the relationship between type 2 diabetes and cardiovascular disease
Our products for COPD
Our products for COPD
Diabetes dog symptoms chronic disease management
Learn about the symptoms of canine diabetes and how to manage the disease.
Fighting against rabies in Nepal
Read about a pilot project of a critical importance which aims to raise awareness and knowledge of rabies in Nepal.
Boehringer Ingelheim Opens New Scientific Office in Kenya as Part of its Commitment to Improve Human and Animal Health in Africa
Boehringer Ingelheim has officially opened its new scientific office in Nairobi, Kenya.
Bees and biodiversity
At Boehringer Ingelheim we attach great importance to sustainable planting on our company site – and to protecting the bees.
Our Innovation Strategy
Our discovery research strategy is designed to sustain our track record of innovation and look for new and breakthrough medicines.
Respiratory Diseases
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in respiratory diseases.
Oncology and Cancer Immunology Research
Find out more about our research and development in oncology and cancer immunology.
Innovation Prize Winners
Find out more about the winners of our Innovation Prize in Boston, New York and San Diego in the USA; Tokyo Japan and Vienna, Austria
Research in Diabetic Macular Ischemia
There are no available treatments for DMI. Scientists at Boehringer Ingelheim are working hard to change this.
Guardians for health
A global initiative to reduce mortality, cardiovascular and kidney complications in type 2 diabetes through adherence to clinical guidelines.
FDA approves NexGard for the prevention Lyme disease in dogs
Boehringer Ingelheim received approval from the U.S. (FDA) to expand the label claims for NexGard, the chewable flea and tick product.
Global poultry trends Professor David Hughes
Professor David Hughes takes us through megatrends in poultry.